Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Hospira Inc. is recalling 9,912 units of 0.9% Sodium Chloride Injection, USP, 250 mL, because human hair was found floating in the IV solution.
The FDA is recalling M1-Alpha Labs Mega Mass Builder capsules because they contain an unapproved synthetic hormone ingredient, making them unapproved new drugs.
The FDA is recalling 7-Ment Alpha Advanced Mass Builder capsules because they contain an unapproved synthetic hormone ingredient.
Detox Transforms is recalling BtRiM Max capsules because they contain undeclared phenolphthalein, making the product an unapproved drug.
Anabolic Science Labs is recalling Professional Formexx Black capsules because they contain an unapproved synthetic hormone ingredient.
Cody Laboratories is recalling 19,139 bottles of C-Topical 4% cocaine hydrochloride because they were incorrectly labeled as 10 mL instead of 4 mL.
Wockhardt USA is recalling specific lots of Captopril Tablets 12.5 mg because they failed to meet thickness specifications.
RemedyRepack Inc. is voluntarily recalling 25 vials of Ketorolac Tromethamine Injection 30 mg/mL due to crystallization. The product was distributed in Pennsylvania and Oklahoma.
Romark Laboratories is recalling specific lots of Alinia (nitazoxanide) powder for oral suspension because the product failed to meet long-term stability specifications for viscosity.
Hospira is voluntarily recalling specific lots of Ketorolac Tromethamine Injections because of crystallization. The affected products were distributed nationwide, in Puerto Rico, and in Guam.
Teva Pharmaceuticals USA is recalling specific lots of Fluoxetine Capsules USP, 20 mg, due to an elevated level of a residual solvent impurity in the active pharmaceutical ingredient.
Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection due to crystallization. The recall covers products distributed nationwide, in Puerto Rico, and in Guam.
Teva Pharmaceuticals USA is recalling specific lots of Fluoxetine Capsules 10 mg due to an elevated level of a residual solvent impurity in the active ingredient.
Attix Pharmaceuticals is recalling Satraplatin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Hydralazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Levocetirizine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Amikacin Sulfate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Paroxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling progesterone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Dantrolene Sodium API lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling acetylsalicyclic acid active pharmaceutical ingredient due to potential penicillin cross-contamination. The product was distributed to compounding pharmacies and research organizations.
Hospira is recalling 0.9% Sodium Chloride Injection, USP, 250 mL, because a human hair was found sealed in the bag at the additive port area.
Attix Pharmaceuticals is recalling Furazolidine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Quinine Sulfate Dihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Histamine Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.